The ratings of 3 Health Care Equipment & Supplies stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Slipping from a C to a D rating, Insulet Corporation (PODD) takes a hit this week. Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of PODD stock.
This week, Haemonetics Corporation’s (HAE) rating worsens to a D from the company’s C rating a week ago. Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The company also gets F’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of HAE stock.
ERBA Diagnostics, Inc. (ERB) gets weaker ratings this week as last week’s D drops to a F. The company also gets F’s in sales growth, operating margin growth, earnings growth, earnings surprise, and return on equity. For more information, get Portfolio Grader’s complete analysis of ERB stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.